Impacts of vaccination on hepatitis b viral infections in Korea over a 25-year period

Intervirology

Volumn 53, Issue 1, 2010, Pages 20-28

  Park, Neung Hwa ^a   Chung, Young Hwa ^b   Lee, Hyo Suk ^c  

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Epidemiology; Hepatitis B vaccine; Hepatitis B virus; Korea

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIGEN DETECTION; CANCER PREVENTION; CANCER RISK; CHILD; CONFERENCE PAPER; DRUG TREATMENT FAILURE; GENETIC VARIABILITY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOPROPHYLAXIS; KOREA; LIVER CELL CARCINOMA; MALE HOMOSEXUAL; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SEROPREVALENCE; SEXUAL BEHAVIOR; TREATMENT OUTCOME; VACCINATION; VERTICAL TRANSMISSION; VIRUS CARRIER;

ADOLESCENT; ADULT; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; INFANT, NEWBORN; KOREA; VACCINATION; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 75349089237     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000252780     Document Type: Conference Paper

References (62)

1. Cha C, Dematteo RP: Molecular mechanisms in hepatocellular carcinoma development. Best Pract Res Clin Gastroenterol 2005; 19: 25-37.
2. Ganem D, Prince AM: Hepatitis B virus infection: natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129.
3. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS: A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34: 1329-1339.
4. Lok AS: Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2004; 127:S303-S309.
5. Korea National Statistical Office: Annual statistical report of causes of death in 2005 (in Korean). 2006.
6. Kim SR, Kudo M, Hino O, Han KH, Chung CH, Lee HS: Epidemiology of hepatocellular carcinoma in Japan and Korea. Oncology 2008; 75: 13-16.
7. Korea National Statistical Office: Annual statistical report of cause of death in 2006 (in Korean). 2007.
8. Han KH, Kim JK: Liver cancer in Korea. Hepatol Res 2007; 37:S106-S109.
9. Huh K, Choi SY, Whang YS, Lee DS: Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma. J Korean Med Sci 1998; 13: 306-310.
10. Cho HH, Kim YH, Jung JM, Cho KH, Cho SH, Choi DH, Jeong SH, Lee JH, Han CJ, Kim YC, Lee JO, Kim CM: Clinical characteristics of non-B, non-C hepatocellular carcinoma and detection of HBV, HCV and TTV viremia (in Korean). Korean J Hepatol 2001; 7: 439-448.
11. World Health Organization: Expanded programme on immunization. Global Advisory Group. Weekly Epidemiol Rec 1992; 3: 11-16.
12. World Health Organization: Statistics on hepatitis B. www.who.int/immunization- monitoring/diseases/HepB-coverage.jpg
13. World Health Organization: Vaccines and biologicals: WHO vaccine preventable disease monitoring system: global summary 2009 (data up to 2008). www.who.int/immunization- monitoring/diseases/HepB-map- schedule.jpg
14. Chen DS: Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol 2009; 50: 805-816.
15. Choe BH: The epidemiology and present status of chronic hepatitis B in Korean children (in Korean). Korean J Pediatr 2008; 51: 696-703.
16. Lee CH: Recommended vaccination schedule against hepatitis A and B. Korean J Med 1998; 55: 715-723.
17. Korea Institute for Health and Social Affairs: National fertility and family health survey (in Korean). 1994.
18. Lee SY, Choi BY, Shin YJ, Bang KN, Ki M, Park HB, Yoon JD, Lee KC, Youn BJ: A seroepidemiological study on hepatitis B vaccination program in elemantary school students from Kyonggi-do province (in Korean). Korean J Pediatr Infectious Dis 1997; 4: 240-256.
19. Korea Centers for Disease Control and Prevention/ Research team for epidemiology: Current state of survey of national immunity (in Korean). 2008.
20. Park JW, Kim BC, Park JH, Kim WY, Koh YI, Rheu D: A survey of positive rates of HBsAg and anti-HBs in a rural area of Korea (in Korean). Korean J Med 1998; 55: 176-184.
21. Kim SJ, Bom HS, Cho KH, Nam KW, Hong KP, Kim JS: A study for HBsAg and anti-HBs positivities in Chonnam and Cheju provincial officials, 1984 (in Korean). Korean J Med 1986; 31: 313-317.
22. Chun BY, Lee MK, Rho YK: The prevalence of hepatitis B surface antigen among Koreans by literature review (in Korean). Korean J Epidemiol 1992; 14: 70-78.
23. Oh EA, Joung NK: A survey of HBs and anti-HBs positivities among 173,342 primary, middle and high school students in Kwangju City and Chonnam Province (in Korean). Kor J Gastroenterol 1990; 22: 825-830.
24. Kim RK, Ahn BM, Lee DS, Lee KM, Park YM, Lee YS, Chung KW, Lee WC, Meng KH: Changes in the positivities of HBsAg and anti-HCV antibody among army draftees in Korea (in Korean). Korean J Hepatol 2000; 6: 474-480.
25. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Lee MS, Park CK, Yoo JY: Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 2001; 16: 153-159.
26. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Yoo JY: The investigation for the change of HBsAg positive rate of grade junior high high-schoolers for recent 3 years in Kangwon province (in Korean). Korean J Med 2000; 58: 608-615.
27. Korea Centers for Disease Control and Prevention: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES III), 2007. 2008, pp 70-71.
28. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR: Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002; 17: 457-462.
29. Ministry of Education, Science and Technology: 2006 report of the sampling analysis results of students' health examination (in Korean). Yonhap News 2007, pp 9-20.
30. Sim JG, Seo JK, Suh SJ: Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children (in Korean). J Korean Pediatr Soc 1995; 38: 1535-1539.
31. An YW, Chung EH, Rheem IS: A study of the current (2003-2005) prevalence of anti-HBs and immunologic memory of hepatitis B vaccine in children from the central area of Korea (in Korean). Korean J Pediatr 2006; 49: 630-634.
32. Ahn YO, Kim YS, Lee MS, Shin MH: Hepatitis B virus infection rate among Koreans (in Korean). Seoul J Med 1992; 33: 105-144.
33. Song EY, Yun YM, Park MH, Seo DH: Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009; 52: 57-62.
34. Lee HS, Byun JH, Kim CY: Etiology and outcome of acute viral hepatitis in Korean adults. J Korean Med Sci 1990; 5: 149-154.
35. Jeong SH: Current status and vaccine indication for hepatitis A virus infection in Korea (in Korean). Korean J Gastroenterol 2008; 51: 331-337.
36. Ministry for Health, Welfare and Family Affairs/ Korea Centers for Disease Control and Prevention: 2008 Guidebook of Hepatitis B Vertical Transmission Prevention Program (in Korean). 2008, pp 6-16.
37. Yim HJ, Chang YJ, Byun KS, Suh YS, Kim JH, Kim JY, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH: The changing patterns of acute hepatitis B infection in Korea in the early 2000s (in Korean). Korean J Med 2005; 69: 601-607.
38. Kim IS, Oh HC, Lee Y, Kim JD, Lee WY: Prevalence and changes of HBsAg and anti-HBs for one year period in natural status and after hepatitis B vaccination (in Korean). Korean J Epidemiol 1987; 9: 40-48.
39. Park BJ, Ahn YO: Cohort study on the asymptomatic chronic carrier rate of hepatitis B virus among male adults in Korea (in Korean). Korean J Epidemiol 1989; 11: 263-273.
40. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855-1859.
41. Lee MS, Kim DH, Kim H, Lee HS, Kim CY, Park TS, Yoo KY, Park BJ, Ahn YO: Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int J Epidemiol 1998; 27: 316-319.
42. Seo K, Park SK, Kim YT, Park O: The prevalence of HBsAg positive parturients in Korea (in Korean). Korean J Obstet Gynecol 2005; 48: 2119-2124.
43. Korea Centers for Disease Control and Prevention: Communicable Diseases Monthly Report: Hepatitis B Vertical Transmission Prevention Program (in Korean). 2008, p 14.
44. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2: 1099-1102.
45. Stevens CE, Beasley RP, Tsui J, Lee WC: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-774.
46. Chung WK, Yoo JY, Sun HS, LeeHY, Lee IJ, Kim SM, Prince AM: Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea. J Infect Dis 1985; 151: 280-286.
47. Kim YJ, Kim SK, Park SH, Yang US, Liu BH: A study on distribution of hepatitis B markers in families of HbsAg-positive blood donors (in Korean). Korean J Med 1983; 26: 884-890.
48. Lee JJ, Kim IM: Intrafamilial spread of hepatitis B virus infection (in Korean). Korean J Med 1982; 25: 1191-1198.
49. Kong H, Kim JH, Cho NY, Kim YH, Jung KM, Yeon JE, Kim JS, Bak YT, Cho KH, Park YK, Byun KS, Lee CH: The hepatitis B carrier rate in siblings of patients with HBV-associated chronic liver disease (in Korean). Korean J Hepatol 2001; 7: 387-391.
50. Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, Yang KH, Lee TY: Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine1991; 9: 457-460.
51. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG: Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27: 100-106.
52. Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW: Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1: 406-410.
53. Lee SD, Lo KJ, Wu JC, Tsai YT, Wang JY, Ting LP, Tong MJ: Prevention of maternalinfant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 1986; 6: 369-373.
54. Korea Centers for Disease Control and Prevention: Report of the Korea Centers for Disease Control and Prevention (in Korean). 2004, pp 365-367.
55. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS: Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007; 166: 813-818.
56. Kang JH, Moon JW, Kong SH, Hwang KS, Mok JS, Lee HJ: Comparison of the seroconversion rate after primary hepatitis B vaccination and after revaccination of non-responders in full-term infants according to mother's HBsAg seropositivity (in Korean). Korean J Pediatr 2008; 51: 1165-1171.
57. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-329.
58. Francois G, Kew M, Van Damme P, Mphahlele M J, Meheus A: Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine 2001; 19: 3799-3815.
59. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS: Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 1997; 26: 786-791.
60. Kim JH, Koh DK, Hur JK, Kang JH, Nainan OV, Margolis HS: The incidence rate of hepatitis B virus surface gene variants in Korean children with immunoprophylaxis failure of perinatal infection (in Korean). Korean J Hepatol 2005; 11: 320-328.
61. Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW: Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 2001; 16: 359-362.
62. Kim B, Seo K, Park S, Kim Y, Park O, Lee HJ, Hong WK, Whang HS: Evaluation of prevention program for neonatal vertical transmission from HBsAg positive mother in Korea (in Korean). Korean J Obstet Gynecol 2005; 48: 2067-2072.